Infrea (INFREA) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
5 Jun, 2025Executive summary
Achieved fourth consecutive quarter of improvements, with EBITA up 134% and strong cash flow despite project write-downs and organizational adjustments.
Net sales for Q4 increased 3.5% year-over-year to 639.8 MSEK; full-year sales rose 3.2% to 2,077.9 MSEK.
EBITA margin improved to 5.3% in Q4 (3.9% last year); full-year EBITA margin at 1.4% (0.6%).
Board proposes a dividend of 0.50 SEK per share, totaling 15.0 MSEK.
Financial highlights
Q4 net income was 22.9 MSEK (13.7 MSEK last year); EPS 0.8 SEK (0.7 SEK).
Full-year net income was -8.0 MSEK (-7.6 MSEK last year); EPS -0.3 SEK (-0.4 SEK).
Q4 operating cash flow reached 86.8 MSEK (71.3 MSEK); full-year operating cash flow 99.7 MSEK (30.4 MSEK).
Räntebärande nettoskuld reduced to 204.7 MSEK (334.6 MSEK); net debt/EBITDA improved to 1.7x (3.4x).
EBITDA for Q4 was 57.7 MSEK (46.8 MSEK); full-year EBITDA 121.0 MSEK (97.4 MSEK).
Outlook and guidance
Management expects continued improvements in project management and risk control, with a more robust financial position heading into 2025.
Anticipates further normalization of project deviations and sees potential for growth, especially as market conditions stabilize.
Latest events from Infrea
- Strategic divestment and operational gains delivered strong growth, net cash, and higher dividend.INFREA
Q4 202517 Feb 2026 - Q3 EBITA up 50% with margin gains; outlook for 2025 remains positive amid market challenges.INFREA
Q3 20257 Nov 2025 - Q2 delivered strong organic growth and margin improvement, despite restructuring costs.INFREA
Q2 202518 Jul 2025 - Q3 EBITA improved but goodwill impairment drove a net loss; cash flow and liquidity strengthened.INFREA
Q3 202413 Jun 2025 - Sales and EBITA improved in Q2, with a stronger order book and balance sheet.INFREA
Q2 202413 Jun 2025 - Strong organic growth and restructuring drive Infrea's Q1, despite continued losses.INFREA
Q1 20255 Jun 2025